Loading...
Interpace Biosciences, Inc.
IDXG•PNK
Healthcare
Medical - Diagnostics & Research
$0.77
$0.004(0.58%)
Interpace Biosciences, Inc. (IDXG) Financial Performance & Statements
Review Interpace Biosciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
16.69%
↑ 16.69%
Operating Income Growth
189.16%
↑ 189.16%
Net Income Growth
735.66%
↑ 735.66%
Operating Cash Flow Growth
22.62%
↑ 22.62%
Operating Margin
18.82%
↑ 18.82%
Gross Margin
64.82%
↑ 64.82%
Net Profit Margin
16.36%
↑ 16.36%
ROE
-119.25%
↓ 119.25%
ROIC
155.83%
↑ 155.83%
Interpace Biosciences, Inc. (IDXG) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Interpace Biosciences, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $12.32M | $12.29M | $12.04M | $10.27M |
| Cost of Revenue | $3.40M | $4.79M | $4.61M | $4.20M |
| Gross Profit | $8.92M | $7.51M | $7.43M | $6.07M |
| Gross Profit Ratio | $0.72 | $0.61 | $0.62 | $0.59 |
| R&D Expenses | $193000.00 | $199000.00 | $146000.00 | $137000.00 |
| SG&A Expenses | $5.65M | $5.40M | $5.03M | $5.06M |
| Operating Expenses | $5.84M | $5.60M | $5.17M | $5.20M |
| Total Costs & Expenses | $9.24M | $10.39M | $9.79M | $9.40M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $111000.00 | $145000.00 | $188000.00 | $216000.00 |
| Depreciation & Amortization | $211000.00 | $85000.00 | $188000.00 | $160000.00 |
| EBITDA | $3.19M | $1.60M | $2.44M | $1.03M |
| EBITDA Ratio | $0.26 | $0.13 | $0.20 | $0.10 |
| Operating Income | $3.07M | $1.91M | $2.26M | $874000.00 |
| Operating Income Ratio | $0.25 | $0.15 | $0.19 | $0.09 |
| Other Income/Expenses (Net) | -$204000.00 | -$539000.00 | -$117000.00 | -$298000.00 |
| Income Before Tax | $2.87M | $1.37M | $2.14M | $576000.00 |
| Income Before Tax Ratio | $0.23 | $0.11 | $0.18 | $0.06 |
| Income Tax Expense | -$8000.00 | $4000.00 | $4000.00 | $4000.00 |
| Net Income | $2.89M | $1.28M | $2.06M | $468000.00 |
| Net Income Ratio | $0.23 | $0.10 | $0.17 | $0.05 |
| EPS | $0.66 | $0.29 | $0.47 | $0.11 |
| Diluted EPS | $0.18 | $0.29 | $0.47 | $0.11 |
| Weighted Avg Shares Outstanding | $4.41M | $4.39M | $4.38M | $4.37M |
| Weighted Avg Shares Outstanding (Diluted) | $4.41M | $4.42M | $4.40M | $4.38M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan